Antiretroviral drugs for HIV infection have enabled most people living with the virus to live long and healthy lives. However ...

While HIV-1 and HIV-2 closely relate and can cause similar health concerns, there are some important differences to know — especially when it comes to transmission, testing, and treatment. HIV-1 and ...

Among some patients with human immunodeficiency virus type 1 (HIV-1) infection who have undergone multiple antiretroviral therapies and have limited options for treatment, new classes of ...

The patient, who had a history of undetectable HIV-1 RNA levels since 1997 while receiving antiretroviral therapy, had remission from AML after salvage chemotherapy (Table S2). HCT was recommended for ...

What Is Idvynso, and Why Does It Matter? Idvynso (doravirine/islatravir) is a fixed-dose combination of two prescription medicines and is taken as a single, once ...

40 million people live with HIV globally, and that number continues to rise. While therapies exist to reduce the amount of HIV in a patient's body and, in turn, reduce HIV symptoms, there remains no ...

Studies have shown that both SARS-CoV-2 and HIV-1 are RNA viruses and have higher mutation rates than DNA viruses. Although both the viruses have been characterized as highly virulent, the manner of ...

The experimental HIV vaccine regimen exhibited an acceptable safety profile and elicited robust immune responses in 99% of trial participants from sub-Saharan Africa. Its ability to induce broad ...

Yet certain details of that virion assembly have been lacking for four decades. In a study published in the journal Proceedings of the National Academy of Sciences, Jamil Saad, Ph.D., and colleagues ...

“There have been as many plagues as wars in history; yet always plagues and wars take people equally by surprise.” ― Albert Camus, The Plague As the world strives to find a cure for the ongoing ...